Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
J
Jing Zhao
W
Wanting Xu
F
Fei Zhou
X
Xiangyu Zhang
M
Mo Zhou
D
Da Miao
L
Lan Yu
Y
Yongchang Zhang
J
Junqiang Fan
C
Caicun Zhou
W
Wen Li
T
Tony Mok
(State Key Laboratory of Translational Oncology, Department of Clinical Oncology The Chinese University of Hong Kong Hong Kong Special Administrative Region Hong Kong China)
X
Xiuning Le
(Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA)
M
Molly Li
Y
Yang Xia
Article Details
Journal
Nature Reviews Clinical Oncology
Volume / Issue
Vol. 23, Issue 1
Published
January 01, 2026
Pages
63-83
ISSN
1759-4774
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Clinical Oncology
Springer Science and Business Media LLC
ISSN: 1759-4774 Q1 Medicine
Authors (15)
J
Jing Zhao
W
Wanting Xu
F
Fei Zhou
X
Xiangyu Zhang
M
Mo Zhou
D
Da Miao
L
Lan Yu
Y
Yongchang Zhang
J
Junqiang Fan
C
Caicun Zhou
W
Wen Li
T
Tony Mok
State Key Laboratory of Translational Oncology, Department of Clinical Oncology The Chinese University of Hong Kong Hong Kong Special Administrative Region Hong Kong China
X
Xiuning Le
Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA
M
Molly Li
Y
Yang Xia
Related Articles from this Journal
Ibrutinib improves overall survival in patients with mantle cell lymphoma
Peter Sidaway
Jul 2026
10.1038/s41571-026-01166-7
First-line zanidatamab–chemotherapy with or without tislelizumab improves survival in advanced-stage HER2+ GEA
Diana Romero
Jul 2026
10.1038/s41571-026-01169-4
Clinical implementation of multi-cancer early detection tests: can we find a path forward?
Ariadna Tibau, Aaron S. Kesselheim
Jul 2026
10.1038/s41571-026-01158-7
Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancer
David Killock
Jul 2026
10.1038/s41571-026-01162-x
Liquid biopsy to inform adjuvant decisions during neoadjuvant chemotherapy — a full-circle moment for nasopharyngeal cancer
W. K. Jacky Lam, Brigette B. Y. Ma
Jul 2026
10.1038/s41571-026-01157-8